title: New technologies for new influenza vaccines.
abstract: The currently available influenza vaccines were developed in the 1930s through the 1960s using technologies that were state-of-the art for the times. Decades of advancement in virology and immunology have provided the tools for making better vaccines against influenza. We now have the means to make vaccines that address some of the shortcomings of the original products, in particular performance in the elderly.
authors.affiliation: VaxInnate, 3 Cedarbrook Drive, Cranbury, NJ 08512, USA. alan.shaw@vaxinnate.com
authors.forename: Alan
authors.initials: A
authors.lastname: Shaw
mesh_terms: D000818:Animals; D001709:Biotechnology / Q000379:methods*; D006801:Humans; D007252:Influenza Vaccines / Q000235:genetics / Q000276:immunology*; D013678:Technology, Pharmaceutical / Q000379:methods*
chemical_list: D007252:Influenza Vaccines